Health
ACROFAN – ACROFAN USA
Preclinical data show Clover’s protein-based adjuvanted COVID-19 vaccine candidate, S-Trimer, induces a strong neutralizing immune response in animalsand protects nonhuman primates from SARS-CoV-2 challengeStrong immune response and protection observed with a…
- Preclinical data show Clovers protein-based adjuvanted COVID-19 vaccine candidate, S-Trimer, induces a strong neutralizing immune response in animalsand protects nonhuman primates from SARS-CoV-2 challenge
- Strong immune response and protection observed with adjuvant systems from GSK and Dynavax led to inclusion of both adjuvants separately into Clovers ongoing Phase 1 clinical trial of S-Trimer
- Clovers ongoing Phase 1 trial of S-Trimer COVID-19 vaccine c…
Continue Reading
-
Noosa News24 hours agoDesign and construction integrity rewarded with national award
-
General9 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News18 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General8 hours agoChina and Philippines trade blame over latest South China Sea clash